World Investment Advisors Buys 20,390 Shares of CVS Health Corporation $CVS

World Investment Advisors boosted its stake in CVS Health Corporation (NYSE:CVS) by 61.1% in the third quarter, HoldingsChannel reports. The firm owned 53,786 shares of the pharmacy operator’s stock after acquiring an additional 20,390 shares during the period. World Investment Advisors’ holdings in CVS Health were worth $4,055,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its position in shares of CVS Health by 1.7% in the 2nd quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock valued at $8,305,132,000 after acquiring an additional 2,063,737 shares during the period. State Street Corp raised its holdings in CVS Health by 1.4% in the second quarter. State Street Corp now owns 58,788,585 shares of the pharmacy operator’s stock worth $4,055,237,000 after purchasing an additional 800,414 shares during the period. Geode Capital Management LLC boosted its position in shares of CVS Health by 2.4% during the second quarter. Geode Capital Management LLC now owns 28,635,233 shares of the pharmacy operator’s stock worth $1,966,083,000 after purchasing an additional 675,824 shares in the last quarter. Invesco Ltd. grew its holdings in shares of CVS Health by 15.3% in the 2nd quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock valued at $1,623,270,000 after buying an additional 3,118,626 shares during the period. Finally, Norges Bank bought a new stake in shares of CVS Health in the 2nd quarter valued at $1,358,698,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Up 0.6%

Shares of CVS Health stock opened at $79.60 on Friday. The firm has a market cap of $101.04 billion, a PE ratio of 209.47, a P/E/G ratio of 0.78 and a beta of 0.48. The business’s 50 day simple moving average is $78.91 and its 200 day simple moving average is $72.90. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. CVS Health Corporation has a 52-week low of $43.65 and a 52-week high of $85.15.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company had revenue of $102.87 billion during the quarter, compared to analysts’ expectations of $98.85 billion. During the same period last year, the business earned $1.09 EPS. The business’s quarterly revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

CVS has been the topic of several recent analyst reports. Evercore ISI lifted their target price on CVS Health from $85.00 to $95.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Argus raised their price target on CVS Health from $80.00 to $91.00 and gave the stock a “buy” rating in a research report on Tuesday, November 4th. Leerink Partners boosted their price objective on CVS Health from $86.00 to $95.00 and gave the company an “outperform” rating in a research report on Thursday, October 16th. Zacks Research downgraded shares of CVS Health from a “strong-buy” rating to a “hold” rating in a report on Monday, September 8th. Finally, TD Cowen lifted their price target on shares of CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, December 10th. Two analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.67.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.